# RxSight, Inc. (RXST): MoatMap facts

As of 24 Oct 2026. Research data, not investment advice.

As of 24 Oct 2026, MoatMap's StockRank for RxSight, Inc. (RXST) is 25/100, ranked against 24,000+ stocks in 35 markets (Quality 40, Value 40, Momentum 30, each scored against its sector).

- StockRank: 25/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 40, Value 40, Momentum 30: each a 0-100 percentile within Healthcare.
- Position: #20,161 overall, #1,757 in Healthcare.
- Listing: United States, NGM; Healthcare / Medical Devices.
- Last close: 5.02 USD on 23 Oct 2026.
- Insider filings, last 180 days: directors sold USD 104K.

Source: https://moatmap.ai/stock/RXST
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker